Form D · Other Health Care
ReShape Lifesciences Inc.
San Clemente, CA · CIK 0001371217
Offering snapshot reported Jul 13, 2018 · SEC filing
- Reported sold
- $2.79M Offering amount: $2.79M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 10, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 13, 2018 | Initial | $2,793,520 | No comparison | 5 | SEC filing |
| Jun 25, 2018 | Initial | $1,537,009 | No comparison | 5 | SEC filing |
| Jun 22, 2018 | Initial | $1,235,413 | No comparison | 4 | SEC filing |
| Oct 17, 2017 | Initial | $61,001,349 | No comparison | 13 | SEC filing |
| Jun 5, 2017 | Initial | $31,291,494 | No comparison | 41 | SEC filing |
| Feb 27, 2009 | Initial | $15,896,351 | No comparison | Not reported | SEC filing |
| Jul 21, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $12.4K
- Finders' fees
- $0
- Form D file number
- 021-316826
The warrants and underlying shares of common stock include warrants (i) to purchase 1,241,382 shares of common stock issued to certain institutional investors and (ii) to purchase 86,897 shares of common stock to H.C. Wainwright ("HCW Warrants").
H.C. Wainwright received the above sales commission in connection with the private placement of warrants. The HCW Warrants were issued to H.C. Wainwright in connection with a registered direct offering by the Company, which is not reported on this Form D.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 375 |
Source: Form D, filed Jul 13, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Naqeeb A Ansari | Executive |
| Gary Blackford | Director |
| Peter M De Lange | Executive |
| Adrianus Jos Donders | Executive |
| Luke Evnin | Director |
| Catherine Friedman | Director |
| Dan Gladney | Director, Executive |
| Carl Goldfischer | Director |
| Bobby I Griffin | Director |
| Donald C Harrison | Director |
| Paul F Hickey | Executive |
| Paul Klingenstein | Director |
| Mark B Knudson | Director, Executive |
| Ellen Koskinas | Director |
| Greg S Lea | Executive |
| Lori Mc Dougal | Director |
| Rajesh Nihalani | Executive |
| Nicholas L Teti | Director |
| Nicholas L Teti, Jr. | Director |
| Jon Tremmel | Director |
| Scott Youngstrom | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1001 Calle Amanecer
San Clemente, CA, 92673
San Clemente, CA, 92673